PPT-Webinar: Strategies for Hepatitis C Treatment Access
Author : aaron | Published Date : 2018-10-29
Stacey Trooskin MD PhD Drexel University amp HepCAP Karen Arendt RN St Josephs Center for Liver amp Hepatobiliary Disease Courtney Jones Patient Advocate Foundation
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Webinar: Strategies for Hepatitis C Trea..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Webinar: Strategies for Hepatitis C Treatment Access: Transcript
Stacey Trooskin MD PhD Drexel University amp HepCAP Karen Arendt RN St Josephs Center for Liver amp Hepatobiliary Disease Courtney Jones Patient Advocate Foundation wwwnvhrorgprogram. Foundation for Faith Based Organizations. www.NYCHepBC.org. . Goals. To understand the liver and it’s role in the body. To understand liver health & disease. To understand Hepatitis C:. How it is Transmitted. Dr. Joanna Eveland, MS, MD. Clinical Chief for Special Populations, MNHC. O. bjectives. Understand recommendations for age cohort and risk based screening for Hepatitis C. Review strategies for health promotion and optimizing treatment readiness for HCV infected homeless individuals. HEPATITIS. Hepatitis. -Is inflammation of the liver. . (. itis. means inflammation and . Hepar. - Liver). Characterised. by irritation or swelling of liver cells(. hepatocytes. ). There are many forms of . Diana L. . Sylvestre. , MD. University of CA, San Francisco. OASIS Clinic, Oakland, CA. Disclosure Information. What’s New In Hepatitis C. Diana . Sylvestre. , MD. I have the following financial relationships to disclose:. Gottfried . Hirnschall. Background . HCV infection significant cause of morbidity and mortality:. 130–150 million persons with chronic HCV infection. 350,000–500,000 annual deaths. Rapidly changing therapeutic environment. Patents, pricing and pharma, Special session » . Pauline Londeix. XX International AIDS conference - AIDS2014 - Melbourne, Australia. Acknowledgments. Special thank to Françoise Barré-Sinoussi & Eric Fleutelot. Slides for today’s webinar are available on the CIHS website at: http://www.integration.samhsa.gov/mai-coc-grantees-online-community/webinars How to ask a question during the webinar If you are listening to this webinar from your computer speakers, please type your questions into the question box and we will address your questions. : inflammation of liver; presence of inflammatory cells in organ tissue. . Pathogenesis: Immune response.. Acute Viral Hepatitis. : symptoms last less than 6 months. Chronic Hepatitis. : Inflammation of liver for at least 6 months. Rachel Stallings, MPH. March 4, 2020. Hepatitis . Hepatitis = inflammation of the liver. Can be self-limiting or progress to fibrosis (scarring), cirrhosis, or liver cancer. . Causes:. Most commonly caused by a virus, there are 5: A, B, C, D & E. C. Dr . Manica. . Balasegaram. , WIPO Seminar, 2014. Generic competition needed. MSF Access Campaign. HIV. :. early successes not sustained. 1. st. line ARVs: no product patent protection in India until 2005 = rock bottom prices. . Cockburn Lecture Theatre, St Marys Hospital. Wednesday 22. nd. May . Prof Ashley Brown. Imperial Healthcare NHS Trust. The cost of NOT treating Viral Hepatitis. HBV. Everything you ever need to know . . TODAY. DIAGNOSIS. TREATMENT. SPECIAL SITUATIONS. COMPLICATIONS. VACCINATION. DIAGNOSIS. Time since infection. Relative amount. HBsAg. Anti-HBs. IgM anti-. HBc. Total anti-. HBc. Serological patterns of acute HBV infection. Navigating Hepatitis C: . What Patients Need to Know . avigating. Hepatitis C: . What Patients Need to Know. Need to Know. HCV Screening. Bruce Burkett. Executive Director. HepC Alliance. Persons who have ever injected illegal drugs, including those who injected only once many years ago. Jocelyn James, MD. Assistant Professor, Department of Medicine. University of Washington. . Adapted from slides developed in collaboration with Judith . Tsui. and the Washington State Department of Health.
Download Document
Here is the link to download the presentation.
"Webinar: Strategies for Hepatitis C Treatment Access"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents